Second-generation antipsychotic medication combinations for schizophrenia

Psychiatric Services

Volumn 59, Issue 3, 2008, Pages 235-

  Eisen, Carol ^a   Shaner, Roderick ^b   Unützer, Jürgen ^c   Fink, Arlene ^d   Wells, Kenneth B ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Los Angeles County   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT; TRANQUILIZER; CHOLINESTERASE INHIBITOR;

DATA BASE; DRUG EFFICACY; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; MENTAL HEALTH CARE; POLYPHARMACY; PRESCRIPTION; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; SHORT SURVEY; AGED; ARTICLE;

AGED; ANTIPSYCHOTIC AGENTS; CHOLINESTERASE INHIBITORS; HUMANS; SCHIZOPHRENIA;

EID: 45749101364     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.59.3.235     Document Type: Short Survey

References (2)

1. Tapp A, Wood AE, Secrest L, et al: Combination antipsychotic therapy in clinical practice. Psychiatric Services 54:55-59, 2003
2. Ascher-Svanum H, Kennedy JS, Lee S, et al: The rate, pattern and cost of nse of antiparkinsonian agents among patients treated for schizophrenia in a managed care setting. American Journal of Managed Care 10:20-24, 2004